• New and expanded facilities include DHL Supply Chain's upcoming Pharma Hub 2, DHL Global Forwarding's Singapore Coldchain Hub, and a dedicated GDP-compliant (Good Distribution Practice-compliant) healthcare space at DHL Express' South Asia Hub
• The investments position Singapore as a regional hub for temperature-sensitive and high-value healthcare supply chain

SINGAPORE - Media OutReach Newswire - 4 September 2026 - Following the opening of its Pharma Hub last year, DHL Group is further strengthening its Life Sciences and Healthcare (LSHC) capabilities in Singapore through a series of investments that enhance its DHL Health Logistics network and expand its capacity to transport, store and distribute pharmaceuticals, medical devices, clinical trial materials and other healthcare products across Asia Pacific. The investments focus on three pillars: infrastructure, specialist expertise, and strategic partnerships. Together, they help maintain product integrity throughout the healthcare supply chain. Asia Pacific's pharmaceutical logistics market is projected to grow from US$163 billion in 2025 to nearly US$239 billion by 2031, driven by rising demand for biologics, vaccines and other temperature-sensitive products that require specialized storage and transportation. As healthcare supply chains become increasingly complex, manufacturers are looking for logistics partners, who can protect product integrity and meet stringent regulatory requirements. To accede to that demand, DHL is putting new infrastructure across its Express, Global Forwarding and Supply Chain businesses, while continuing to grow its healthcare expertise and build closer ties across the broader logistics ecosystem. The investments also build on DHL Group's broader commitment to LSHC and the continued expansion of DHL Health Logistics including the €500 million earmarked for Asia Pacific as part of €2 billion global investment in the sector announced in 2025. The program covers infrastructure and technology across storage, order fulfilment, distribution, global transportation and last-mile delivery. Infrastructure: Singapore Coldchain Hub, Pharma Hub 2, and dedicated GDP-compliant space at South Asia Hub DHL Global Forwarding is strengthening Singapore's role in regional healthcare trade through the DHL Singapore Coldchain Hub, a dedicated healthcare logistics facility that will form part of DHL's broader Health Logistics Air Freight Network connecting key pharmaceutical and life sciences markets worldwide. By combining global air connectivity with specialized healthcare handling capabilities, the network helps customers move sensitive pharmaceutical and life sciences shipments with greater reliability, visibility and temperature integrity across critical healthcare trade lanes. Together with a pharmaceutical corridor initiative being developed with ecosystem partners, the investment will help create more seamless, compliant and resilient healthcare supply chains across Asia Pacific and key healthcare trade lanes. Located within Changi's 24/7 Free Trade Zone at Changi Nexus One, the S$22 million (€15 million) facility will provide 3,047 sqm of GDP-aligned temperature-controlled infrastructure for high-value, time- and temperature-sensitive healthcare cargo, including pharmaceuticals, vaccines, and biologics. With dedicated 2°C to 8°C and 15°C to 25°C handling environments, the facility is designed to support an unbroken cold chain from aircraft to a DHL facility and onward to customers' warehouses, minimizing temperature excursions and reducing the need for supplementary temperature-control measures and packaging while preserving product integrity throughout transit. The facility is slated for launch in late 2027. "In healthcare logistics, precision is non-negotiable. A temperature excursion of just a few degrees can compromise the integrity of high-value medicines, biologics and other critical healthcare products. That is why building an end-to-end, unbroken cold chain is essential. Beyond protecting products, it gives healthcare companies the confidence that life-saving therapies can move safely, compliantly, and reliably across increasingly complex global supply chains. By combining specialized infrastructure, direct airside connectivity and dedicated temperature-controlled handling solutions, our new Singapore Coldchain Hub will help minimize product exposure throughout the shipment journey and give customers greater assurance that their products will arrive in the right condition, at the right time, to the patients who depend on them," added Praveen Gregory, CEO, DHL Global Forwarding Singapore, Malaysia and Indonesia. DHL Supply Chain is building on the success of the Pharma Hub first launched in Singapore last year with a second pharma hub to further expand its healthcare logistics footprint in the...